Back to Top Skip to main content Skip to sub-navigation

Fibromyalgia: Prevalence and Burden of Disease Among Active Component Service Fibromyalgia: Prevalence and Burden of Disease Among Active Component Service Members, U.S. Armed Forces, 2018

Back pain. Credit: iStock.com/Albina Gavrilovic Back pain.
Credit: iStock.com/Albina Gavrilovic

Recommended Content:

Medical Surveillance Monthly Report

WHAT ARE THE NEW FINDINGS?

The prevalence of fibromyalgia (FM) among the active component of the U.S. Armed Forces has not been evaluated since the change from ICD-9 to ICD-10 diagnosis coding, which allows for more accurate capture of FM diagnoses. The estimated prevalence of FM was 0.15% in calendar year 2018.

WHAT IS THE IMPACT ON READINESS AND FORCE HEALTH PROTECTION?

Although the prevalence of FM was low in this study population, the high number of healthcare encounters per affected individual constitute a relatively large burden of disease. The average number of encounters per patient per year was 57 (range=1–263). This clearly presents a significant concern for the readiness and performance of these patients.

ABSTRACT

This report uses routinely collected data in the Defense Medical Surveillance System (DMSS) to characterize the prevalence and burden of fibromyalgia (FM) among members of the active component of the U.S. Armed Forces of FM was 0.15%. There was a trend of increasing prevalence with increasing age. Prevalence was highest among women (0.59%), those in the oldest age group (0.52%), non-Hispanic blacks (0.25%), those in the Air Force (0.21%), those in a healthcare occupation (0.36%), senior enlisted (0.24%) and warrant officers (0.24%). The prevalence of FM was approximately twice as high among non-Hispanic blacks compared to non-Hispanic whites. The average number of medical encounters per FM patient per year was 57 (median 38, LQ=21, UQ=66, range=1–263) compared to an average of 13 in the total patient population. The groups of conditions most commonly associated with an FM diagnosis were musculoskeletal and mental health conditions. The burden of FM disease poses clear readiness and retention concerns.

BACKGROUND

Fibromyalgia (FM) is a common cause of widespread musculoskeletal pain.1 The American College of Rheumatology (ACR) created diagnostic criteria for Widespread Pain Index and symptom severity scale.2 In order for a diagnosis of FM to be made a syndrome of focal areas of pain, not explainable by other conditions, must be present in at least 4 of 5 regions of the body and must have been present for at least 3 months, potentially including other somatic symptoms.2 FM is present in 1.75% of the civilian population according to data from the 2012 National Health Interview Survey.3 Walitt et al. found that FM occurred predominantly in women, beginning in the second decade of life, increased with age, and had similar prevalence by race with the exception of a lower prevalence in Asians.3 These findings are consistent with the results of several studies of FM prevalence in the U.S.1,3,4   

Patients with an FM diagnosis have comorbid conditions at 1.45 times the rate of those without an FM diagnosis.5 Mental disorders, diseases of the musculoskeletal system, and painful neuropathic disorders among other comorbid conditions occur frequently in FM patients.6 FM can be a prolonged and debilitating condition that is difficult to manage, especially given its association with increased comorbidities. The severity and frequency of symptoms can make employment difficult for those with FM.7

In a 2008 study, White and colleagues found that the prevalence of disability was approximately twice as high in patients with FM compared to their peers without FM.7 FM patients in the White et al. study missed an average of 30 days of work per year.7 Patients with FM are often frequent consumers of health care services, utilizing care at a rate 5 times that of the insured U.S. population and averaging up to 6.9 visits per 3-month period.8 Absenteeism and presenteeism (the concept of reduced performance at work due a specific cause) are important to consider as well. Chandran and colleagues found that up to 20% of FM patients reported missing 5 or more days of work in the past month.8 Patients in this study also reported that up to 252 days of work per year were adversely affected by FM.8

Results of a 2017 study of women veterans suggested that exposure to environmental, physical, and psychological stressors associated with military and combat duty increased the risk of developing FM in this population.9 Prevalence of FM among U.S. military members was last formally assessed in a 2014 study that reported an increasing prevalence of FM from 0.31% in 2006 to 0.52% in 2010.10 However, this study estimated FM prevalence among all TRICARE beneficiaries, not just active component service members and relied on the nonspecific International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for FM (729.1, myalgia and myositis, unspecified). Using this code likely resulted in inflated counts of FM diagnoses because active component personnel typically experience muscle strain at rates higher than the general population. The current study describes the prevalence of FM in active component service members and the corresponding burden on FM patients and the Military Health System (MHS).

METHODS

The surveillance period was from 1 January 2018 through 31 December 2018. The surveillance population included all individuals who served in the active component of the U.S. Army, Navy, Air Force, or Marine Corps. All data used in this analysis were derived from records routinely maintained in the Defense Medical Surveillance System (DMSS). These records capture information from care received in military and civilian treatment facilities so long as they were reimbursed through the MHS.

For this study, a case was defined as an active component service member with at least 1 inpatient hospitalization during 2018 for which the DMSS record showed a diagnosis for FM (ICD-10 M79.7) in any diagnostic position or at least 2 outpatient visits within 365 days (at least one of the encounters must have been in 2018) with FM diagnosed in any diagnostic position. Prevalence was calculated by dividing the total number of unique individuals meeting the preceding criteria by the population at the midpoint of the year. Mid-year population was used because the active component of the armed forces is an open population with members entering and leaving throughout the year. The following demographic information was captured for each patient at mid-year: age, sex, race/ethnicity group, branch of service, rank, and military occupation.

The numbers of hospitalizations, bed days, and outpatient encounters were totaled for all individuals diagnosed with FM in 2018 to quantify the burden of FM. For this FM burden calculation, the inpatient or outpatient encounter must have had a diagnosis of FM in the first diagnostic position. Only one encounter per patient per day was counted with priority given to inpatient encounters.

The burden of illness and injury comorbidities among the prevalent cases of FM was tabulated in accordance with previously published methodology used for the MSMR burden of disease reports.11 For those who met the case definition for FM, all illness and injury diagnoses recorded in the first diagnostic position of an inpatient or outpatient encounter during calendar year 2018 were ascertained. These encounters were then grouped into 25 burden of disease major categories based on a modified version of the Global Burden of Disease Study.12 Again, only one encounter per patient per day was included in the analysis. These comorbid diagnoses were also grouped by the 17 ICD10 chapters with the 5 most frequently diagnosed conditions reported for each chapter.

RESULTS

In 2018, a total of 1,955 active component service members met the case definition for FM. This count of cases represents a total prevalence of 0.15% (Table 1). Prevalence increased linearly with age from 0.042% in the 17-24 age group to 0.52% in the 45+ age group. FM was 9.29 times more common in women than men. The prevalence of FM in non-Hispanic blacks (0.245%) was 2 times higher than that in the non-Hispanic white (0.12%) population, and prevalence was very similar between whites and Asian/Pacific Islanders (0.11%). FM was most common in the Air Force (0.21%) and least common in the Marine Corps (0.06%). Senior enlisted and warrant officers were diagnosed with FM at similar levels (both 0.24%), while junior enlisted had the lowest levels (0.06%). Communications/intelligence and healthcare personnel had the greatest prevalence of FM diagnosis compared to other occupational groups (0.24% and 0.36%, respectively), while combat-specific occupations had a relatively low prevalence of 0.04% (Table 1).

In 2018, there was 1 inpatient encounter with the ICD-10 code for FM in the first diagnostic position. Other diagnosis codes listed in the discharge summary for this admission included eosinophilia, abdominal pain, constipation, and leaving against medical advice. There were 6,801 outpatient encounters with FM in the first diagnostic position among 1,535 individual patients meeting criteria to be considered a patient with FM in this study (data not shown). This represents an average of 4.4 outpatient encounters attributable to FM per patient with FM per year. Patients with FM had an average of 57 medical encounters per year (median 38, LQ = 21, UQ = 66, range=1–263) (data not shown). The MSMR burden of disease report for the same year found that all active component service members had an average of 13 encounters per year.

Encounters for comorbid conditions were counted for all 1,955 prevalent cases of FM. The 5 MSMR burden of disease major categories of diagnoses with the most encounters among the 1,955 FM cases in 2018 were musculoskeletal diseases (26.9% of all encounters), mental health disorders (24.3%), injury/poisoning (12.7%), neurologic conditions (10.2%), and signs, symptoms and ill-defined conditions (7.3%) (Figure 1). These 5 burden of disease major categories accounted for 81.4% of all FM patient encounters in 2018. Among patients with FM, nearly all (96.3%; n=1883) had an encounter for a musculoskeletal disease (Table 2), accounting for 25,842 encounters. Within the major category of musculoskeletal disease, the two most common sub-categories were ‘all other musculoskeletal diseases’ (n=14,099), and ‘other back problems’ (n = 10,920) (data not shown). The sub-category ‘all other musculoskeletal diseases’ included the diagnosis of FM. Within the mental health disorders (n=23,299) category, the two most common sub-categories were anxiety disorders (n=9,421) and mood disorders (n=6,904). The two most common sub-categories within injury/poisoning (n=12,221) were arm and shoulder injuries (n=3,464) and knee injuries (n=2,333). Within neurologic conditions (n=9,786) the 2 most common sub-categories were organic sleep disorders (n=5,382) and ‘all other neurologic conditions’ (n=4,144) (excluding epilepsy, multiple sclerosis, and mononeuritis). Lastly, within signs and symptoms (n=6,975) the 2 most common sub-categories were ‘abdomen and pelvis’ (n=1,405) and ‘all other signs and symptoms’ (n=4,414) (excluding the only other category, ‘respiratory and chest’ (n=1,183)) (data not shown).

Outpatient encounters were also quantified according to ICD-10 chapters and specific ICD-10 diagnostic codes (Table 3, 4a, and 4b). The distribution of diagnoses was broadly similar for men and women. The top 5 comorbid diagnoses by ICD-10 major diagnostic category for FM patients were for musculoskeletal system disorders (30.5%), mental health disorders (20.1%), factors influencing health status and contact with health services (17.0%), disorders of the nervous system and sense organs (12.6%), and signs, symptoms, and ill-defined conditions (7.9%) (Table 3).The 2 most common diagnoses within the musculoskeletal system chapter were fibromyalgia and low back pain, comprising 19.4% and 17.9% of all musculoskeletal system primary diagnoses, respectively. Within the mental health disorders category, post-traumatic stress disorder (PTSD) and adjustment disorder were the 2 most common diagnoses accounting for 26.5% and 9.4% of mental health disorder-related outpatient encounters, respectively (Tables 4a, 4b). Among nervous system and sense organ diagnoses obstructive sleep apnea and chronic pain were the most common with 29.0% and 26.1% of encounters, respectively. Lastly, within the signs, symptoms, and ill-defined conditions chapter, pelvic and perineal pain accounted for 11.7% of visits and headache accounted for 7.1% of visits.

EDITORIAL COMMENT

The period prevalence of FM in the active component of the U.S. armed forces was found to be 0.15% in 2018 based on diagnoses made in medical encounters. Prevalence in the U.S. was 1.75% based on diagnoses made via modified ACR criteria based on responses to the 2012 National Health Interview Survey.3 Jeffery et al. found a prevalence of 0.52% in 2010 among all TRICARE beneficiaries including active duty, dependents, and retirees.10 The Jeffery et al. study utilized the ICD-9 code ‘myalgia and myositis, unspecified’ which they acknowledge likely misclassified the outcome by including additional conditions such as myalgia, a common diagnosis for the active component.10 

The marked difference in the prevalence estimate from the current analysis (0.15%) and that reported by Walitt et al. (1.75%) is likely partially explained by differences in methodology. In the Walitt et al. study, only 27% of respondents diagnosed with FM via the survey reported having the FM diagnosis. Applying this percentage to their reported prevalence yields a prevalence of formally diagnosed FM of 0.47%. The remaining difference may be partially explained by the healthy worker effect, the younger age of the active component population, and/or the disincentive for seeking care among active component service members (e.g., loss of flight privileges).

The Armed Forces have strict retention criteria, which may have also contributed to the low prevalence observed in this study. For example, the Air Force Medical Standards Directory states that patients with "fibromyalgia requiring regular use of controlled medications, schedule II-IV, or requiring frequent follow up or duty restrictions" are not qualified for retention.13 The document does not define the frequency of follow up. Similar language is present in the Department of Defense Instruction 6490.07 and DoD Instruction 1332.45 (Deployment Limiting Medical Conditions for Service Members and DoD Civilian Employees and Retention Determinations for Non-Deployable Service Members respectively).14,15 Patients with FM within the active component had an average of 4.4 FM-related outpatient encounters and 57 total medical encounters per year. These counts represent a 3 to 4-fold increase above those seen in the total active component. Such levels of healthcare utilization may result in those with FM not being retained in the Armed Forces, contributing to a lower prevalence. Such personnel losses represent a significant amount of time and impact on readiness.

The trend of increasing prevalence with age in the active component is similar to that seen in the U.S. civilian population.3 In addition, the difference in prevalence between men and women (1:9) is similar to that reported in the published literature.1,3-7 More senior ranks had greater prevalence consistent with the age trend, but senior officers were the exception. This finding may represent some protective feature of this population or it may be that men comprise a greater portion of the senior officer population. Individuals in healthcare occupations had the greatest prevalence of FM. This observation may be explained by the comparative ease of making/keeping appointments, reduced stigma surrounding FM in a healthcare setting, or increased awareness of the condition. Prevalence in non-Hispanic Blacks was more than twice as high as that in non-Hispanic Whites. This relationship was not evident in the literature reviewed. It may be that non Hispanic Blacks experience barriers to care, and thus barriers to diagnosis/capture, in the civilian population, whereas, this effect may not be present in the military health system due to universal access to care. There is no clear explanation of this finding in the data, so this is a topic that deserves future research.

There is a marked difference in the distribution of mental health diagnoses between the FM patient population and the total active component (as described in the annual MSMR burden of disease reports11). Mental health diagnoses comprise twice the percentage of encounters in the FM population compared to the total active component. In 2018, PTSD accounted for more than a quarter of the encounters among active component service members affected by FM which is double the proportion in the total active component population in the same year. These data support existing theory that emotional stress can precipitate or exacerbate FM.16 These comorbidities pose a substantial burden to the readiness of these patients. 

The limitations of this study include potential misclassification bias due to the case definition for FM. Patients who had FM but did not have an encounter with FM as a diagnosis in 2018 were not included in the prevalence estimate. Those who were being ruled out for FM may have been included in the prevalence estimate despite not truly having FM. This was a study of the active component of the U.S. Armed Forces and thus has limited generalizability outside of this population. This was a cross-sectional study without evaluation of an exposure of interest.

This study established the prevalence and burden of FM in the active component as well as the burden of comorbidities among patients with FM. FM requiring frequent follow up is grounds for a medical evaluation board and subsequent separation. This was a cross-sectional study and thus did not provide longitudinal data. A future study in which a cohort of patients with FM were followed would be useful in addressing several knowledge gaps. Such a study could assess whether patients with FM are receiving standard of care, if the frequency of encounters related to the quality of care, and which patients are medically separated. Answers to these questions would give actionable information regarding the FM patient population.

Author affiliations: Madigan Army Medical Center, Joint Base Lewis-McChord, WA (Maj Hulse); Armed Forces Health Surveillance Division, Silver Spring, MD (Dr. Stahlman, Ms. Fedgo, Dr. Beason Serafica, and CDR Clausen).

Disclaimer: The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views, assertions, opinions, or policies of the Uniformed Services University of the Health Sciences (USUHS), the Department of Defense (DoD), or the Departments of the Army, Navy, or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.

REFERENCES

1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.

2. Wolfe F, Clauw DJ, Fitzcharles M, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016; 46(3):319–329.

3. Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PloS One. 2015;10(9): e0138024.

4. Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37(9): 1527–1539.

5. Berger A, Sadosky A, Dukes EM, Edelsberg J, Zlateva G, Oster G. Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care. 2010;16(5 Suppl):S126–S137.

6. Lachaine J, Beauchemin, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain. 2010;26(4):284–290.

7. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50(1):13–24.

8. Chandran A, Schaefer C, Ryan K, Baik R, McNett M, Zlateva G. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and crosssectional survey of working-age US adults. J Mang Care Pharm. 2012;18(6):415–426.

9. D'Aoust RF, Rossiter AG, Elliott A, Ji M, Lengacher C, Groer M. Women veterans, a population at risk for fibromyalgia: The associations between fibromyalgia, symptoms, and quality of life. Mil Med. 2017;182(7):e1828–e1835.

10. Jeffery DD, Bulathsinhala L., Kroc M, Dorris J. Prevalence, health care utilization, and costs of fibromyalgia, irritable bowel, and chronic fatigue syndromes in the military health system, 2006–2010. Mil Med. 2014;179(9):1021–1029.

11. Armed Forces Health Surveillance Branch. Ambulatory visits, active component, U.S. Armed Forces, 2018. MSMR. 2019;26(5):19–25.

12. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996:120–122.

13. Department of the Air Force. U.S. Air Force Medical Standards Directory. Approved by AF SG3C. 13 May 2020.

14. Department of Defense. Instruction 6490.07, Deployment-Limiting Medical Conditions for Service Members and DoD Civilian Employees. 5 February 2010.

15. Office of the Under Secretary of Defense for Personnel and Readiness. Department of Defense Instruction 1332.45, Retention Determinations forNon-Deployable Service Members. 30 July 2018.

16. Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114–129.

FIGURE. Percentage of medical encountersa attributable to burden of disease major categories,b service members with FM, active component, U.S. Armed Forces, 2018

TABLE 1. Demographic and military characteristics of patients diagnosed with FM, active component, U.S. Armed Forces, 2018

TABLE 2. Medical encounters, individuals affected, and hospital bed days, by burden of disease major category, service members with FM, active component, U.S. Armed Forces, 2018

TABLE 3. Medical encounters, individuals affected, and hospital bed days, by ICD-10 major diagnostic category, service members with FM, active component, U.S. Armed Forces, 2018

TABLE 4a. Most frequent diagnoses during ambulatory visits by ICD-10 major diagnostic category, male service members with FM, active component, U.S. Armed Forces, 2018

TABLE 4b. Most frequent diagnoses during ambulatory visits by ICD-10 major diagnostic category, female service members with FM, active component, U.S. Armed Forces, 2018

You also may be interested in...

Incidence, Timing, and Seasonal Patterns of Heat Illnesses During U.S. Army Basic Combat Training, 2014–2018

Article
4/1/2019
U.S. Marines participate in morning physical training during a field exercise at Marine Corps Base Camp Pendleton, California. (Photo Courtesy: U.S. Marine Corps)

Risk factors for heat illnesses (HIs) among new soldiers include exercise intensity, environmental conditions at the time of exercise, a high body mass index, and conducting initial entry training during hot and humid weather when recruits are not yet acclimated to physical exertion in heat. This study used data from the Defense Health Agency’s–Weather-Related Injury Repository to calculate rates and to describe the incidence, timing, and geographic distribution of HIs among soldiers during U.S. Army basic combat training (BCT). From 2014 through 2018, HI events occurred in 1,210 trainees during BCT, resulting in an overall rate of 3.6 per 10,000 BCT person-weeks (p-wks) (95% CI: 3.4–3.8). HI rates (cases per 10,000 BCT p-wks) varied among the 4 Army BCT sites: Fort Benning, GA (6.8); Fort Jackson, SC (4.4); Fort Sill, OK (1.8); and Fort Leonard Wood, MO (1.7). Although the highest rates ofHIs occurred at Fort Benning, recruits in all geographic areas were at risk. The highest rates of HI occurred during the peak training months of June through September, and over half of all HI cases affected soldiers during the first 3 weeks of BCT. Prevention of HI among BCT soldiers requires relevant training of both recruits and cadre as well as the implementation of effective preventive measures.

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2003–2018

Article
4/1/2019
Drink water the day before and during physical activity or if heat is going to become a factor. (Photo Courtesy: U.S. Air Force)

From 2003 through 2018, there were 1,579 incident diagnoses of exertional hyponatremia among active component service members, for a crude overall incidence rate of 7.2 cases per 100,000 person-years (p-yrs). Compared to their respective counterparts, females, those less than 20 years old, and recruit trainees had higher overall incidence rates of exertional hyponatremia diagnoses. The overall incidence rate during the 16-year period was highest in the Marine Corps, intermediate in the Army and Air Force, and lowest in the Navy. Overall rates during the surveillance period were highest among Asian/Pacific Islander and non-Hispanic white service members and lowest among non-Hispanic black service members. Between 2003 and 2018, crude annual incidence rates of exertional hyponatremia peaked in 2010 (12.7 per 100,000 p-yrs) and then decreased to 5.3 cases per 100,000 p-yrs in 2013 before increasing in 2014 and 2015. The crude annual rate in 2018 (6.3 per 100,000 p-yrs) represented a decrease of 26.5% from 2015. Service members and their supervisors must be knowledgeable of the dangers of excessive water consumption and the prescribed limits for water intake during prolonged physical activity (e.g., field training exercises, personal fitness training, and recreational activities) in hot, humid weather.

Recommended Content:

Medical Surveillance Monthly Report

Update: Heat Illness, Active Component, U.S. Armed Forces, 2018

Article
4/1/2019
Drink water the day before and during physical activity or if heat is going to become a factor. (Photo Courtesy: U.S. Air Force)

In 2018, there were 578 incident diagnoses of heat stroke and 2,214 incident diagnoses of heat exhaustion among active component service members. The overall crude incidence rates of heat stroke and heat exhaustion diagnoses were 0.45 cases and 1.71 cases per 1,000 person-years, respectively. In 2018, subgroup-specific rates of incident heat stroke diagnoses were highest among males and service members less than 20 years old, Asian/Pacific Islanders, Marine Corps and Army members, recruit trainees, and those in combat-specific occupations. Subgroup-specific incidence rates of heat exhaustion diagnoses in 2018 were notably higher among service members less than 20 years old, Asian/Pacific Islanders, Army and Marine Corps members, recruit trainees, and service members in combat-specific occupations. During 2014–2018, a total of 325 heat illnesses were documented among service members in Iraq and Afghanistan; 8.6% (n=28) were diagnosed as heat stroke. Commanders, small unit leaders, training cadre, and supporting medical personnel must ensure that the military members whom they supervise and support are informed about the risks, preventive countermeasures, early signs and symptoms, and first-responder actions related to heat illnesses.

Recommended Content:

Medical Surveillance Monthly Report

Modeling Lyme Disease Host Animal Habitat Suitability, West Point, New York

Article
4/1/2019
A deer basks in the morning sun at Joint Base San Antonio-Fort Sam Houston, Texas.  (Photo Courtesy: U.S. Air Force)

As the most frequently reported vector-borne disease among active component U.S. service members, with an incidence rate of 16 cases per 100,000 person-years in 2011, Lyme disease poses both a challenge to healthcare providers in the Military Health System and a threat to military readiness. Spread through the bite of an infected blacklegged tick, infection with the bacterial cause of Lyme disease can have lasting effects that may lead to medical discharge from the military. The U.S. Military Academy at West Point is situated in a highly endemic area in New York State. To identify probable areas where West Point cadets as well as active duty service members stationed at West Point and their families might contract Lyme disease, this study used Geographic Information System mapping methods and remote sensing data to replicate an established spatial model to identify the likely habitat of a key host animal—the white-tailed deer.

Recommended Content:

Medical Surveillance Monthly Report

Heat Illness

Infographic
4/1/2019
Heat Illness

This report summarizes reportable medical events of heat illness as well as heat illness-related hospitalizations and ambulatory visits among active component service members during 2018 and compares them to the previous 4 years. Episodes of heat stroke and heat exhaustion are summarized separately.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Exertional Rhabdomyolysis

Infographic
4/1/2019
Exertional Rhabdomyolysis

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Exertional Hyponatremia

Infographic
4/1/2019
Exertional Hyponatremia

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Lyme Disease

Infographic
4/1/2019
Lyme Disease

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Sexually Transmitted Infections

Infographic
3/20/2019
Sexually Transmitted Infections

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Vasectomy

Infographic
3/20/2019
Vasectomy

There are few published studies of vasectomy and vasectomy reversal among the U.S. military population. To address these gaps, the current analysis describes the overall and annual incidence rates of vasectomy among active component service men during 2000–2017 by demographic and military characteristics and by type of surgical vas isolation procedure used. In addition, the median age at incident vasectomy and the time between incident vasectomy and first vasectomy reversal are described.

Recommended Content:

Health Readiness | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Male Infertility

Infographic
3/20/2019
Male Infertility

The current report updates and expands on the findings of the previous MSMR analysis of infertility among active component service men. Specifically, the current report summarizes the frequencies, rates, temporal trends, types of infertility, and demographic and military characteristics of infertility among active component service men during 2013–2017.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Testosterone Replacement Therapy

Infographic
3/20/2019
Testosterone Replacement Therapy

With the increasing number of testosterone deficiency diagnoses and potential health risks associated with initiation of TRT, it is important to understand the epidemiology of which U.S. service men are receiving TRT and whether these individuals have an indication for receiving treatment.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Brief Report: Male Infertility, Active Component, U.S. Armed Forces, 2013–2017

Article
3/1/2019
Sperm is the male reproductive cell  Photo: iStock

Infertility, defined as the inability to achieve a successful pregnancy after 1 year or more of unprotected sexual intercourse or therapeutic donor insemination, affects approximately 15% of all couples. Male infertility is diagnosed when, after testing both partners, reproductive problems have been found in the male. A male factor contributes in part or whole to about 50% of cases of infertility. However, determining the true prevalence of male infertility remains elusive, as most estimates are derived from couples seeking assistive reproductive technology in tertiary care or referral centers, population-based surveys, or high-risk occupational cohorts, all of which are likely to underestimate the prevalence of the condition in the general U.S. population.

Recommended Content:

Medical Surveillance Monthly Report

Vasectomy and Vasectomy Reversals, Active Component, U.S. Armed Forces, 2000–2017

Article
3/1/2019
Sperm is the male reproductive cell  Photo: iStock

During 2000–2017, a total of 170,878 active component service members underwent a first-occurring vasectomy, for a crude overall incidence rate of 8.6 cases per 1,000 person-years (p-yrs). Among the men who underwent incident vasectomy, 2.2% had another vasectomy performed during the surveillance period. Compared to their respective counterparts, the overall rates of vasectomy were highest among service men aged 30–39 years, non-Hispanic whites, married men, and those in pilot/air crew occupations. Male Air Force members had the highest overall incidence of vasectomy and men in the Marine Corps, the lowest. Crude annual vasectomy rates among service men increased slightly between 2000 and 2017. The largest increases in rates over the 18-year period occurred among service men aged 35–49 years and among men working as pilots/air crew. Among those who underwent vasectomy, 1.8% also had at least 1 vasectomy reversal during the surveillance period. The likelihood of vasectomy reversal decreased with advancing age. Non-Hispanic black and Hispanic service men were more likely than those of other race/ethnicity groups to undergo vasectomy reversals.

Recommended Content:

Medical Surveillance Monthly Report

Testosterone Replacement Therapy Use Among Active Component Service Men, 2017

Article
3/1/2019
Image of Marines carrying a wooden log for physical fitness. Click to open a larger version of the image.

This analysis summarizes the prevalence of testosterone replacement therapy (TRT) during 2017 among active component service men by demographic and military characteristics. This analysis also determines the percentage of those receiving TRT in 2017 who had an indication for receiving TRT using the 2018 American Urological Association (AUA) clinical practice guidelines. In 2017, 5,093 of 1,076,633 active component service men filled a prescription for TRT, for a period prevalence of 4.7 per 1,000 male service members. After adjustment for covariates, the prevalence of TRT use remained highest among Army members, senior enlisted members, warrant officers, non-Hispanic whites, American Indians/Alaska Natives, those in combat arms occupations, healthcare workers, those who were married, and those with other/unknown marital status. Among active component male service members who received TRT in 2017, only 44.5% met the 2018 AUA clinical practice guidelines for receiving TRT.

Recommended Content:

Medical Surveillance Monthly Report
<< < ... 6 7 8 9 10  ... > >> 
Showing results 136 - 150 Page 10 of 14

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.